Cortica

Cortica

Cortica was co-founded by Dr. Suzanne Goh, a pediatric neurologist and board-certified behavior analyst, and Dr. Neil Hattangadi, who serves as CEO. The company delivers what it calls a "Whole-Child Model," merging medical care and developmental therapies to treat autism and other neurodevelopmental differences. The leadership team includes executives overseeing strategy, technology, operations, and a clinical innovation network co-directed by Elysa Marco and Kevin Shapiro. The firm deploys a multi-disciplinary clinical model with diagnostic evaluations, ABA therapy, speech-language pathology, occupational therapy, physical therapy, music therapy, and mental health counseling. Its Jumpstart early intervention program targets children under five through intensive group sessions focused on social, communication, and cognitive skills. Cortica operates physical centers in California, Texas, Illinois, and Massachusetts and accepts most major insurance plans, positioning itself as an in-network scaled provider rather than a cash-pay clinic. The company states that its therapy leads to significantly greater improvement on Vineland-3 adaptive behavior scores and publishes clinical outcomes studies. Adam Boehler, former director of the Center for Medicare and Medicaid Innovation, serves as an investor and strategic advisor to the company. Former North Carolina Health Secretary Kody Kinsley also advises the firm. Cortica provides care for autism, ADHD, epilepsy, genetic syndromes, and sensory processing disorders and refers to its patient base as a population served comprehensively under one roof. Its centers accept patient referrals via direct enrollment and provider fax, with mental health counseling delivered through telehealth. Cortica organizes around a physician-led, multi-disciplinary practice where an employed medical team directs behavioral, sensorimotor, and biomedical therapies — an architecture distinct from the franchise-owner model common in autism services. The inclusion of both a Chief Medical Officer and a Co-Director structure for the Cortica Innovation Network signals a stated commitment to clinical research embedded inside an operating company, rather than inside an academic medical center.